X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21887) 21887
Publication (3724) 3724
Book Chapter (217) 217
Book Review (211) 211
Dissertation (64) 64
Conference Proceeding (47) 47
Newsletter (29) 29
Government Document (11) 11
Reference (5) 5
Book / eBook (4) 4
Data Set (3) 3
Streaming Video (2) 2
Trade Publication Article (2) 2
Web Resource (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12462) 12462
index medicus (10610) 10610
animals (8744) 8744
proteasome endopeptidase complex - metabolism (5993) 5993
biochemistry & molecular biology (5105) 5105
proteasome (4702) 4702
cell biology (4349) 4349
proteasome inhibitors (4300) 4300
mice (4195) 4195
proteins (4158) 4158
apoptosis (4016) 4016
oncology (3557) 3557
ubiquitin (3519) 3519
bortezomib (3259) 3259
cell line, tumor (3085) 3085
degradation (2988) 2988
cancer (2899) 2899
proteasome endopeptidase complex (2884) 2884
male (2606) 2606
research (2536) 2536
female (2382) 2382
ubiquitin - metabolism (2347) 2347
proteolysis (2309) 2309
expression (2299) 2299
phosphorylation (2278) 2278
cell line (2276) 2276
ubiquitin-proteasome system (2220) 2220
article (2099) 2099
activation (1993) 1993
ubiquitination (1948) 1948
signal transduction (1932) 1932
apoptosis - drug effects (1754) 1754
multidisciplinary sciences (1746) 1746
cysteine endopeptidases - metabolism (1740) 1740
rats (1698) 1698
proteasomes (1697) 1697
physiological aspects (1683) 1683
multienzyme complexes - metabolism (1682) 1682
gene expression (1631) 1631
nf-kappa-b (1590) 1590
antineoplastic agents - pharmacology (1584) 1584
leupeptins - pharmacology (1583) 1583
cells, cultured (1564) 1564
research article (1537) 1537
cells (1536) 1536
protein (1516) 1516
mutation (1491) 1491
proteasome inhibitor (1454) 1454
analysis (1348) 1348
protein binding (1339) 1339
genetic aspects (1322) 1322
multiple myeloma (1322) 1322
biology (1320) 1320
cell cycle (1318) 1318
oxidative stress (1315) 1315
pathway (1305) 1305
hematology (1274) 1274
cysteine proteinase inhibitors - pharmacology (1262) 1262
pharmacology & pharmacy (1245) 1245
medicine (1225) 1225
autophagy (1168) 1168
health aspects (1167) 1167
inhibition (1163) 1163
neurosciences (1142) 1142
in-vivo (1116) 1116
kinases (1113) 1113
blotting, western (1102) 1102
proteasome inhibitors - pharmacology (1096) 1096
transfection (1092) 1092
gene-expression (1068) 1068
boronic acids - pharmacology (1045) 1045
amino acid sequence (1039) 1039
science (1033) 1033
hela cells (1029) 1029
enzymes (1009) 1009
molecular sequence data (1002) 1002
ubiquitin-proteasome pathway (995) 995
antineoplastic agents - therapeutic use (992) 992
enzyme inhibitors - pharmacology (991) 991
pyrazines - pharmacology (987) 987
down-regulation (970) 970
in-vitro (970) 970
immunology (959) 959
biochemistry (953) 953
inhibitors (952) 952
protease inhibitors - pharmacology (949) 949
multiple myeloma - drug therapy (936) 936
ubiquitin-protein ligases - metabolism (930) 930
dose-response relationship, drug (928) 928
multiple-myeloma (909) 909
proteasome endopeptidase complex - genetics (879) 879
time factors (874) 874
signal transduction - drug effects (862) 862
middle aged (860) 860
genetics & heredity (853) 853
biophysics (842) 842
care and treatment (831) 831
tumor cells, cultured (829) 829
nf-kappa b - metabolism (817) 817
models, biological (801) 801
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21822) 21822
Japanese (90) 90
Chinese (62) 62
French (41) 41
German (35) 35
Russian (29) 29
Korean (23) 23
Polish (23) 23
Czech (11) 11
Ukrainian (3) 3
Hungarian (2) 2
Spanish (2) 2
Catalan (1) 1
Portuguese (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BIOCHEMICAL PHARMACOLOGY, ISSN 0006-2952, 07/2015, Volume 96, Issue 1, pp. 1 - 9
Proteasome inhibitors have a 20 year history in cancer therapy. The first proteasome inhibitor, bortezomib (Velcade, PS-341), a break-through multiple myeloma... 
MULTIPLE-MYELOMA | IXAZOMIB | CELLS | Bortezomib | MLN9708 | CEP-18770 | ANTITUMOR-ACTIVITY | PS-341 | THERAPY | Ixazomib citrate | PHASE-I TRIAL | Carfilzomib | PHARMACOLOGY & PHARMACY | TUMOR-GROWTH | Proteasome
Journal Article
Journal Article
Nature, ISSN 0028-0836, 02/2016, Volume 530, Issue 7589, pp. 233 - 236
The proteasome is a multi-component protease complex responsible for regulating key processes such as the cell cycle and antigen presentation(1). Compounds... 
VISUALIZATION | FALCIPARUM MALARIA | MECHANISM | SPECIFICITY | ARTEMISININ RESISTANCE | MULTIDISCIPLINARY SCIENCES | VALIDATION | ELECTRON-MICROSCOPY | IDENTIFICATION | PARASITE | HUMAN 20S PROTEASOME | Plasmodium falciparum - enzymology | Plasmodium - enzymology | Plasmodium chabaudi - enzymology | Species Specificity | Humans | Proteasome Inhibitors - chemistry | Plasmodium - drug effects | Plasmodium falciparum - drug effects | Protein Subunits - metabolism | Dose-Response Relationship, Drug | Artemisinins - pharmacology | Plasmodium chabaudi - physiology | Drug Design | Plasmodium - growth & development | Female | Drug Resistance | Antimalarials - adverse effects | Catalytic Domain | Proteasome Inhibitors - pharmacology | Models, Molecular | Proteasome Endopeptidase Complex - chemistry | Proteasome Inhibitors - toxicity | Proteasome Inhibitors - adverse effects | Antimalarials - pharmacology | Cryoelectron Microscopy | Drug Synergism | Animals | Substrate Specificity - drug effects | Proteasome Endopeptidase Complex - ultrastructure | Antimalarials - chemistry | Plasmodium chabaudi - drug effects | Mice | Mice, Inbred BALB C | Protein Subunits - antagonists & inhibitors | Protein Subunits - chemistry | Antimalarials - toxicity | Enzyme Activation | Plasmodium falciparum - growth & development | Proteasome Endopeptidase Complex - metabolism | Ubiquitin-proteasome system | Plasmodium | Health aspects | Proteins | Malaria | Protease inhibitors | Proteases | Erythrocytes | Ligands | Parasites | Drug dosages
Journal Article
Journal Article
Biochemical Journal, ISSN 0264-6021, 09/2013, Volume 454, Issue 2, pp. 201 - 208
NAC (N-acetyl-L-cysteine) is commonly used to identify and test ROS (reactive oxygen species) inducers, and to inhibit ROS. In the present study, we identified... 
Catalase | N-acetyl-L-cysteine (NAC) | Proteasome inhibitor | Reactive oxygen species (ROS) | Forkhead box protein M1 (FOXM1) | CANCER-CELLS | TARGET | APOPTOSIS | OXIDATIVE STRESS | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | reactive oxygen species (ROS) | ENDOPLASMIC-RETICULUM STRESS | BORTEZOMIB | FOXM1 | INACTIVATION | proteasome inhibitor | LACTACYSTIN | catalase | Free Radical Scavengers - pharmacology | Oxidants - pharmacology | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Acetylcysteine - metabolism | Proteasome Inhibitors - chemistry | Proteasome Inhibitors - metabolism | Viral Proteins - metabolism | Antineoplastic Agents, Phytogenic - antagonists & inhibitors | Chromans - metabolism | Proteasome Endopeptidase Complex - drug effects | Chromans - pharmacology | Dioxolanes - pharmacology | Forkhead Transcription Factors - metabolism | Forkhead Transcription Factors - antagonists & inhibitors | Ubiquitinated Proteins - metabolism | Recombinant Proteins - metabolism | Recombinant Proteins - antagonists & inhibitors | Free Radical Scavengers - metabolism | Proteasome Inhibitors - pharmacology | Catalase - genetics | Chromans - antagonists & inhibitors | Hydrogen Peroxide - pharmacology | Viral Proteins - genetics | Oxidants - antagonists & inhibitors | Dioxolanes - antagonists & inhibitors | Forkhead Transcription Factors - genetics | Catalase - metabolism | Reactive Oxygen Species - antagonists & inhibitors | Protein Stability - drug effects | Acetylcysteine - pharmacology | Cell Line, Tumor | Cytomegalovirus - enzymology | Proteasome Endopeptidase Complex - metabolism | Antineoplastic Agents, Phytogenic - pharmacology | Forkhead Box Protein M1 | Hydrogen Peroxide - antagonists & inhibitors | N-acetyl-l-cysteine (NAC)
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 07/2015, Volume 96, Issue 1, pp. 1 - 9
Proteasome inhibitors have a 20 year history in cancer therapy. The first proteasome inhibitor, bortezomib (Velcade, PS-341), a break-through multiple myeloma... 
Carfilzomib | Bortezomib | MLN9708 | Ixazomib citrate | Proteasome | Antineoplastic Agents - pharmacology | Antineoplastic Agents - therapeutic use | Proteasome Inhibitors - pharmacology | Humans | Proteasome Inhibitors - therapeutic use | Neoplasms - drug therapy
Journal Article
Cell Death and Disease, ISSN 2041-4889, 10/2012, Volume 3, Issue 10, pp. e411 - e411
The strategy of clinically targeting cancerous cells at their most vulnerable state during mitosis has instigated numerous studies into the mitotic cell death... 
Chemotherapy | Mitotic slippage | Tumor growth | Antimitotic | Cancer | ADVANCED SOLID TUMORS | mitotic slippage | POLO-LIKE KINASES | CELL-CYCLE ARREST | antimitotic | HUMAN BREAST-CANCER | DEPENDENT KINASE INHIBITOR | chemotherapy | CHRONIC MYELOID-LEUKEMIA | SMALL-MOLECULE INHIBITOR | CELL BIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | tumor growth | CHRONIC LYMPHOCYTIC-LEUKEMIA | cancer | SPINDLE PROTEIN INHIBITOR | Anaphase-Promoting Complex-Cyclosome | Humans | Ubiquitin-Protein Ligase Complexes - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Multiprotein Complexes - antagonists & inhibitors | DNA-Binding Proteins - metabolism | Multiprotein Complexes - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Molecular Motor Proteins - antagonists & inhibitors | Molecular Motor Proteins - metabolism | Antineoplastic Agents - pharmacology | Protein-Serine-Threonine Kinases - metabolism | DNA-Binding Proteins - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Adenosine Triphosphatases - metabolism | Proteasome Endopeptidase Complex - chemistry | Enzyme Inhibitors - therapeutic use | Neoplasms - drug therapy | Adenosine Triphosphatases - antagonists & inhibitors | Mitosis - drug effects | Ubiquitin-Protein Ligase Complexes - metabolism | Myeloid Cell Leukemia Sequence 1 Protein | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Proteasome Endopeptidase Complex - metabolism | Review
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2018, Volume 128, Issue 7, pp. 2760 - 2762
Journal Article